|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-3
|
|
pubmed:abstractText |
Cyclooxygenase-2 (COX-2) overexpression has been associated with a poor prognosis in many cancers. However, the role of COX-2 overexpression in head and neck cancers remains undetermined. The objective of this study was to evaluate whether COX-2 is a prognostic factor in glottic cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
67-73
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18172254-Aged,
pubmed-meshheading:18172254-Carcinoma, Squamous Cell,
pubmed-meshheading:18172254-Cyclooxygenase 2,
pubmed-meshheading:18172254-Double-Blind Method,
pubmed-meshheading:18172254-Female,
pubmed-meshheading:18172254-Glottis,
pubmed-meshheading:18172254-Head and Neck Neoplasms,
pubmed-meshheading:18172254-Humans,
pubmed-meshheading:18172254-Immunohistochemistry,
pubmed-meshheading:18172254-Kaplan-Meier Estimate,
pubmed-meshheading:18172254-Laryngeal Neoplasms,
pubmed-meshheading:18172254-Male,
pubmed-meshheading:18172254-Middle Aged,
pubmed-meshheading:18172254-Neoplasms, Second Primary,
pubmed-meshheading:18172254-Placebos,
pubmed-meshheading:18172254-Prognosis,
pubmed-meshheading:18172254-Tumor Markers, Biological,
pubmed-meshheading:18172254-Vitamins,
pubmed-meshheading:18172254-alpha-Tocopherol
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
|
|
pubmed:affiliation |
Pathology Department, Centre Hospitalier Universitaire de Québec and Université Laval, Quebec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|
